LadRx Corporation (LADX)
OTCMKTS · Delayed Price · Currency is USD
1.770
-0.320 (-15.31%)
Aug 28, 2025, 10:04 AM EDT
LadRx Market Cap
LadRx has a market cap or net worth of $876.31 thousand as of August 28, 2025. Its market cap has decreased by -9.23% in one year.
Market Cap
876.31K
Enterprise Value
669.36K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.77
Market Cap Chart
Since April 5, 1988, LadRx's market cap has decreased from 83.03M to 876.31K, a decrease of -98.94%. That is a compound annual growth rate of -11.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 876.31K | 5.36% |
| Dec 31, 2024 | 831.76K | 29.23% |
| Dec 29, 2023 | 643.62K | -87.57% |
| Dec 30, 2022 | 5.18M | -73.55% |
| Dec 31, 2021 | 19.58M | -69.32% |
| Dec 31, 2020 | 63.84M | 554.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 840.66M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 654.71M |
| Elite Pharmaceuticals | 610.28M |
| CytoDyn | 401.32M |
| Northwest Biotherapeutics | 390.55M |
| American Oncology Network | 376.01M |